Pathstone Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,181
Closed -$586K 2297
2025
Q1
$586K Buy
9,181
+279
+3% +$17.8K ﹤0.01% 1641
2024
Q4
$1.08M Buy
8,902
+1,785
+25% +$217K ﹤0.01% 1329
2024
Q3
$889K Sell
7,117
-160
-2% -$20K ﹤0.01% 1434
2024
Q2
$1.15M Buy
7,277
+226
+3% +$35.7K 0.01% 1246
2024
Q1
$913K Buy
7,051
+2,441
+53% +$316K ﹤0.01% 1327
2023
Q4
$445K Buy
+4,610
New +$445K ﹤0.01% 1580